| Financial Year |
March 31 2023 |
| Monetary Funds |
362,262,199.93 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
412,979,664.15 |
| Advances to Suppliers |
68,788,924.70 |
| Other Receivables |
52,105,161.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
418,944,118.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,486,200.78 |
| Total Current Assets |
1,416,547,234.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
69,273,555.58 |
| Investment Properties |
8,430,312.76 |
| Fixed Assetes |
1,050,127,946.65 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
76,088,882.29 |
| R&D expenses |
-- |
| Goodwill |
4,472,232.85 |
| Long-Term Deferred and Prepaid Expenses |
5,079,665.87 |
| Deferred Income Tax Assets |
51,807,669.54 |
| Other Non-Current Assets |
24,536,049.92 |
| Sub-Total of Non-Current Assets |
1,290,849,909.60 |
| Total Assets |
2,707,397,143.84 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,600,200.00 |
| Accounts Payable |
439,668,238.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,053,730.69 |
| Taxes Payable |
38,692,746.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,511,955.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,566,573.07 |
| Other Current Liabilities |
8,387,828.87 |
| Sub-Total of Current Liabilities |
642,308,723.73 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
26,600,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,231,309.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
303,179,130.66 |
| Total Liabilities |
945,487,854.39 |
| Paid-In Capital(Or Share Stock) |
510,657,000.00 |
| Capital Surplus |
343,511,317.07 |
| Surplus Reserve |
112,675,094.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
774,403,434.61 |
| Minority Stockholder's Interest |
19,065,047.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,742,844,242.35 |
| Owner's Equity（Stockholder's Equity） |
1,761,909,289.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,707,397,143.84 |
